FDA approval of teprotumumab as therapeutic offers hope for patients.
Andrew R. Harrison, MD
Advertisement
Articles by Andrew R. Harrison, MD
Advertisement
Latest Updated Articles
Advancement in TED treatment is a bright spotPublished: June 30th 2021 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Idebenone accepted by FDA for priority review for Leber Hereditary Optic Neuropathy
2
Luxa Biotechnology announces clinical trial results for treatment of AMD
3
STAAR Surgical confirms expiration of “window shop” period in Alcon merger agreement
4
The European Commission grants marketing authorization for EYLUXVI
5
.png "Optometry Times"){kind=logo}
